The cost of minimally invasive surgery for prostate enlargement is about $8,000 to $15,000, and the commonly used surgical procedure is the minimally invasive treatment of prostate enlargement by common electrosurgical endoluminal enucleation under low-pressure bladder perfusion (TUERP). Minimally invasive surgery for prostatic hyperplasia is easy to be carried out in primary hospitals due to its less trauma, scientific safety, better efficacy, simple operation, lower instrumentation requirements, lower cost, easy to grasp and popularize, thorough prostatectomy, and fewer complications, and is now being widely promoted to hospitals at all levels across the country. Minimally invasive surgery for prostate enlargement can largely solve the problems of large trauma, high medical cost, incomplete surgical resection and poor prognosis in the treatment of prostate enlargement patients.